Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe

  • Sandoz and Austrian government announce joint plans to drive long-term competitiveness of European production for key antibiotics in Europe
     
  • Planned combined investment of more than EUR 150 million would include major innovative technology development and implementation for large-scale manufacture of active ingredients for leading penicillin products
     
  • Kundl manufacturing site in Austria is hub of last vertically integrated antibiotics production chain in Europe; Sandoz is #1 global supplier of generic antibiotics …
/by

New Novartis analysis shows wet AMD patients achieved sustained fluid control faster with Beovu® versus aflibercept

  • A post-hoc analysis of the HAWK and HARRIER trials presented at ASRS showed >=50% of patients achieved sustained retinal dryness by weeks 8 and 4 with Beovu and by weeks 12 and 8 with aflibercept, respectively1
     
  • The analysis also showed >=75% of patients reached sustained dryness by weeks 32 and 20 with Beovu and by weeks 56 and 52 with aflibercept in HAWK and HARRIER, respectively1
     
  • Retinal fluid is a key sign of wet AMD disease activity and drying the retina is a core aim of treatment2 …
/by
Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe
  • Sandoz and Austrian government announce joint plans to drive long-term competitiveness of European production for key antibiotics in Europe
  • Planned combined investment of more than EUR 150 million would include major innovative technology development and implementation for large-scale manufacture of active ingredients for leading penicillin products
  • Kundl manufacturing site in Austria is hub of last vertically integrated antibiotics production chain in Europe; Sandoz is #1 global supplier of generic antibiotics

Holzkirchen, July 27 …

/by